ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

INVO INVO BioScience Inc

0,93
0,00 (0,00%)
08 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
INVO BioScience Inc INVO NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 0,93 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,93
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
06.5.202423:30EDGAR2Form 8-K - Current report
17.4.202416:25APSMicro Cap Massively Bid Up Before Opening Bell
16.4.202422:59GLOBEINVO Reports Fourth Quarter and Full Year 2023 Financial..
06.2.202416:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01.2.202415:01EDGAR2Form 8-K - Current report
23.1.202414:00GLOBENAYA Biosciences To Acquire Clinical Stage Gene Therapy..
17.1.202414:00GLOBEINVO Bioscience Files S-4 Registration and Preliminary Joint..
16.1.202423:29EDGAR2Form S-4 - Registration of securities, business combinations
10.1.202422:46EDGAR2Form 8-K/A - Current report: [Amend]
10.1.202422:05EDGAR2Form 8-K - Current report
03.1.202423:29EDGAR2Form 8-K - Current report
28.12.202323:04EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
28.12.202323:02EDGAR2Form 8-K - Current report
13.12.202323:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
13.12.202322:53EDGAR2Form 8-K - Current report
11.12.202314:00PRNUSNAYA Biosciences Announces Publication of New Data for its..
28.11.202323:18EDGAR2Form 8-K - Current report
28.11.202315:00PRNUSINVO Bioscience Regains Compliance with Nasdaq Minimum..
24.11.202319:08EDGAR2Form DEF 14A - Other definitive proxy statements
20.11.202322:59EDGAR2Form 8-K - Current report
13.11.202322:10EDGAR2Form 8-K - Current report
13.11.202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202322:01PRNUSINVO Reports Record Third Quarter 2023 Financial Results
13.11.202315:23EDGAR2Form SC TO-C - Written communication relating to an issuer..
13.11.202315:21EDGAR2Form 8-K - Current report
13.11.202315:12EDGAR2Form PRE 14A - Other preliminary proxy statements
10.11.202315:00PRNUSNAYA Biosciences and INVO Bioscience Announce Appointment of..
09.11.202322:40PRNUSINVO Bioscience Announces Commencement of Waiver..
27.10.202315:00PRNUSFree Registration Is Now Open For Tribe Public's CEO and Q&A..
26.10.202322:56EDGAR2Form 8-K - Current report
24.10.202323:10EDGAR2Form 8-K - Current report
23.10.202313:30PRNUSINVO Bioscience and NAYA Biosciences Announce Definitive..
16.10.202312:15EDGAR2Form 8-K - Current report
11.10.202315:00PRNUSINVO to Participate in the Lytham Partners Fall 2023..
05.10.202322:28EDGAR2Form 8-K - Current report
03.10.202323:24EDGAR2Form 8-K - Current report
02.10.202323:12EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29.9.202323:26EDGAR2Form 8-K - Current report
29.9.202322:05PRNUSINVO BIOSCIENCE ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF..
28.9.202318:45EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
28.9.202318:30PRNUSINVO Reminds Shareholders to Cast Their Vote for Upcoming..
08.9.202322:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01.9.202323:17EDGAR2Form 8-K - Current report
01.9.202315:55EDGAR2Form DEF 14A - Other definitive proxy statements
21.8.202322:33EDGAR2Form PRE 14A - Other preliminary proxy statements
14.8.202322:10EDGAR2Form 8-K - Current report
14.8.202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.8.202322:05PRNUSINVO Reports Second Quarter 2023 Financial Results
11.8.202322:18EDGAR2Form SC 13G - Statement of acquisition of beneficial..
11.8.202320:07EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

Delayed Upgrade Clock